FindTrial
Sign In

inalimarev

BIOLOGICAL2 trials

Sponsors

Michael Morse, MD, National Cancer Institute (NCI)

Conditions

Colorectal CancerLocally Advanced Pancreatic AdenocarcinomaMetastatic CancerPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaStage III Pancreatic Cancer AJCC v6 and v7Stage IV Pancreatic Cancer AJCC v6 and v7

Phase 1

Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Active, not recruitingNCT00669734
National Cancer Institute (NCI)Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma +2
Start: 2010-02-01End: 2027-04-21Updated: 2026-04-23

Phase 2

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer
CompletedNCT00103142
Michael Morse, MDColorectal Cancer, Metastatic Cancer
Start: 2005-02-28End: 2013-03-31Updated: 2015-10-14

Related Papers

A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.
2013-12-0194 citations